The evidence against breast screening continues to flow in:
Trends in incidence and detection of advanced
breast cancer at biennial screening
mammography in The Netherlands: a population
Joost Nederend1*, Lucien EM Duijm1, Adri C Voogd2,3, Johanna H Groenewoud4, Frits H Jansen1 and
Marieke WJ Louwman
Conclusion: We observed no decline in the risk of advanced breast cancer during 12 years of biennial screening
mammography. The majority of these cancers could not have been prevented through earlier detection at
Screening has not delivered on its promises. The risk of
being diagnosed with advanced breast cancer today is the
same as before screening, which is why screening has not
reduced breast cancer mortality [5,6] or mastectomy use
. However, the risk of being diagnosed with breast
cancer has increased by 50% in the screened age group
due to overdiagnosis , with severe consequences for
those who experience it. Screening for breast cancer has
turned out to be very complex and hard to justify.
JNCI | Articles Page 1 of 14
© The Author 2012. Published by Oxford University Press. All rights reserved.
For Permissions, please e-mail: firstname.lastname@example.org.
Mammography Screening and Breast Cancer
Mortality in Sweden
P. Autier, A. Koechlin, M. Smans, L. Vatten, M. Boniol
Conclusion County-specific mortality statistics in Sweden are consistent with studies that have reported limited or no impact
of screening on mortality from breast cancer.